These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19047176)

  • 1. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
    Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis of the hepatocyte growth factor/MET signaling pathway in pediatric medulloblastoma.
    Onvani S; Terakawa Y; Smith C; Northcott P; Taylor M; Rutka J
    Genes Chromosomes Cancer; 2012 Jul; 51(7):675-88. PubMed ID: 22447520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.
    Hwang S; Kim HE; Min M; Raghunathan R; Panova IP; Munshi R; Ryu B
    J Invest Dermatol; 2015 Sep; 135(9):2283-2291. PubMed ID: 25910030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.
    Fukushima T; Kawaguchi M; Yamamoto K; Yamashita F; Izumi A; Kaieda T; Takezaki Y; Itoh H; Takeshima H; Kataoka H
    Cancer Sci; 2018 Sep; 109(9):2970-2979. PubMed ID: 29987920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration.
    Provençal M; Labbé D; Veitch R; Boivin D; Rivard GE; Sartelet H; Robitaille Y; Gingras D; Béliveau R
    Carcinogenesis; 2009 Jul; 30(7):1089-96. PubMed ID: 19359592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer.
    Dong W; Chen X; Xie J; Sun P; Wu Y
    Int J Cancer; 2010 Oct; 127(7):1526-34. PubMed ID: 20063316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
    Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC
    Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
    Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
    Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Met receptor signaling: a key effector in esophageal adenocarcinoma.
    Anderson MR; Harrison R; Atherfold PA; Campbell MJ; Darnton SJ; Obszynska J; Jankowski JA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5936-43. PubMed ID: 17062664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma.
    Vibhakar R; Foltz G; Yoon JG; Field L; Lee H; Ryu GY; Pierson J; Davidson B; Madan A
    Neuro Oncol; 2007 Apr; 9(2):135-44. PubMed ID: 17329407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
    Chang Q; Ng HK
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
    Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
    Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
    FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
    Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
    Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.